Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

MNMD
Mind Medicine (MindMed) Inc. Common Shares
stock NASDAQ

At Close
May 14, 2025 3:59:30 PM EDT
6.53USD+2.512%(+0.16)780,638
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 14, 2025 9:14:30 AM EDT
6.31USD-0.942%(-0.06)6,737
After-hours
May 14, 2025 4:38:30 PM EDT
6.56USD+0.459%(+0.03)3,486
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
10:13AM EST  Psyched: UK Streamlines MDMA Therapy, FDA OKs MindMed's First LSD Trial In 40 years, Atai Launches Subsidiary   Benzinga
Jan 27, 2022
05:12PM EST  Bruce Linton's skare Capital Announces Strategic Cannabis Investment Partnership   Benzinga
Jan 26, 2022
08:09AM EST  MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years   Benzinga
Jan 25, 2022
09:00AM EST  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jan. 25, 2022: MSFT, SHOP, ERIC, MNMD, TSLA   Benzinga
07:53AM EST  Why MindMed Is Rising In Pre-market?   RTTNews
07:40AM EST  FDA Clears MindMed IND For MM-120 In Treatment Of Generalized Anxiety Disorder; Stock Up   RTTNews
07:33AM EST  FDA Clears MindMed IND For MM-120 In Treatment Of Generalized Anxiety Disorder   Benzinga
Jan 24, 2022
09:15AM EST  Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri   Benzinga
Jan 19, 2022
10:49AM EST  MindMed Successfully Completes Phase 1 Trial Of 18-MC   Benzinga
Jan 18, 2022
01:42PM EST  MindMed Launches Study Using Monitoring System For Psychedelic Experiences   Benzinga
07:32AM EST  MindMed Enrolls First Participant In Study Of Its Session Monitoring System   Benzinga
Jan 10, 2022
02:17PM EST  Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth   Benzinga
08:53AM EST  Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington   Benzinga
Jan 7, 2022
04:41PM EST  Stephen Hurst Resigns from MindMed Board of Directors   PR Newswire
Jan 4, 2022
10:08AM EST  MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine   Benzinga
07:30AM EST  MindMed Successfully Completes Phase 1 Clinical Trial Of 18-MC   Benzinga
Dec 30, 2021
09:37AM EST  2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?   Benzinga
07:30AM EST  MindMed to Participate at the LifeSci Partners 11th Annual Corporate Access   PR Newswire
Dec 29, 2021
03:30PM EST  Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams   Benzinga
07:30AM EST  MindMed Announces Transitions to Management Team   PR Newswire
Dec 22, 2021
02:06PM EST  MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder   Benzinga
Dec 21, 2021
12:20PM EST  'Another Washington City Moves To Decriminalize Psychedelics, With Unanimous Council Vote' -Marijuana Moment Report   Benzinga
11:03AM EST  'GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs: "One of the things we've done in the past is we've put things on Schedule I and then we've not researched it."' -Marijuana Moment   Benzinga
08:02AM EST  Mind Medicine (MindMed) Inc. (MNMD) said the FDA has placed a clinical hold on its IND submission intended to support the initiation of a phase 2b trial of lysergic acid diethylamide for the treatment of generalized anxiety disorder.   RTTNews
07:37AM EST  MindMed : FDA Places Clinical Hold On IND Submission On Generalized Anxiety Disorder; Stock Down   RTTNews
07:32AM EST  MindMed Announces FDA Has Issued A Clinical Hold On Initial IND Submission For Phase 2b Trial Of LSD For Treatment of Generalized Anxiety Disorder   Benzinga
07:31AM EST  MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the   PR Newswire
Dec 17, 2021
03:49PM EST  'Activists File Colorado Ballot Initiatives To Legalize Psychedelics And Establish 'Healing Center' Program' -Marijuana Moment Report   Benzinga
01:16PM EST  MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD   Benzinga
12:52PM EST  'Congressman Asks Colleagues To Demand DEA Allow Psilocybin Treatment For Terminal Patients' -Marijuana Moment Report   Benzinga
07:35AM EST  MindMed Initiates Phase 2a LSD Trial For Treatment Of Adult Attention Deficit Hyperactivity Disorder   RTTNews
07:32AM EST  MindMed Reports Initiation Of Phase 2a LSD Trial For Treatment Of Adult ADHD   Benzinga
07:31AM EST  MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD   PR Newswire
Dec 15, 2021
08:14AM EST  Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne   Benzinga
Dec 14, 2021
10:24AM EST  MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups   Benzinga
08:20AM EST  Mind Medicine (MindMed) Inc.(MNMD), a company focused on psychedelic-inspired therapies, said on Tuesday that Robert Barrow has been named as its new chief executive officer or CEO.   RTTNews
07:35AM EST  MindMed Appoints Robert Barrow As Chief Executive Officer And Director   Benzinga
07:33AM EST  MindMed Appoints Robert Barrow As CEO And Director   RTTNews
07:31AM EST  MindMed Appoints Robert Barrow as Chief Executive Officer and Director   PR Newswire
Dec 12, 2021
03:54PM EST  Fintech Focus For December 13, 2021   Benzinga
Dec 10, 2021
04:21PM EST  EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline   Benzinga
Dec 9, 2021
09:57PM EST  From Benzinga's Global Small Cap Conference: MindMed CEO, Robert Barrow Begins Presenting   Benzinga
09:56PM EST  Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study   Benzinga
09:50PM EST  FDA Shows Support For Development Of MindMed's Session Monitoring System   Benzinga
09:46PM EST  MindMed Engages In Productive Pre-Submission Meeting With FDA For Development Of The MindMed Session Monitoring System   Benzinga
09:46PM EST  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Dec. 9, 2021 (Benzinga Global Small Cap Conference Edition): AMYT, YTEN, WRAP, RCRT, MNMD   Benzinga
07:33AM EST  MindMed Engages In Pre-Submission Meeting With FDA For Development Of MindMed Session Monitoring System   RTTNews
07:31AM EST  MindMed Engages in Productive Pre-Submission Meeting with FDA for Development   PR Newswire
Dec 6, 2021
11:19AM EST  'DEA Backs White House Plan To Streamline Research On Marijuana, Psychedelics And Other Schedule I Drugs' -Marijuana Moment Report   Benzinga
Dec 2, 2021
09:09AM EST  'DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT' -Marijuana Moment Report   Benzinga
07:31AM EST  MindMed to Participate at the Benzinga Global Small Cap Conference   PR Newswire
Dec 1, 2021
07:31AM EST  MindMed to Present at H.C. Wainwright 2nd Annual Psychedelics Conference   PR Newswire
Nov 30, 2021
04:58PM EST  Antidepressants Can Be Used During Psilocybin Treatment, A New MindMed & Liechti Lab Study Finds   Benzinga
07:31AM EST  MindMed and Liechti Lab publish first human data on the interacting effects of   PR Newswire
Nov 16, 2021
01:07PM EST  MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD   Benzinga
07:35AM EST  MindMed Launches Study Of Low-Dose LSD Effects On Sleep And Cognitive Measures   Benzinga
Nov 15, 2021
10:57AM EST  Mind Medicine Q3 Net Loss $24.3M   Benzinga
07:31AM EST  Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical Pipeline   PR Newswire
Nov 12, 2021
07:31AM EST  MindMed to Present at the Jefferies London Healthcare Conference   PR Newswire
Nov 11, 2021
08:43PM EST  Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty   Benzinga
Nov 9, 2021
01:49PM EST  '$CMPS Largest psilocybin trial finds the psychedelic is effective in treating serious depression...' -Tweet From STAT News' Adam Feuerstein   Benzinga
Nov 5, 2021
07:31AM EDT  MindMed Appoints Dr. Maria Oquendo to its Scientific Advisory Board   PR Newswire
Nov 3, 2021
11:24AM EDT  Mind Medicine Option Alert: Nov 19 $2.5 Calls Sweep (25) near the Ask: 584 @ $0.43 vs 50155 OI; Earnings 11/23 Before Open [est] Ref=$2.725   Benzinga
Nov 2, 2021
04:48PM EDT  Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?   Benzinga
Nov 1, 2021
12:39PM EDT  Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation   Benzinga
07:31AM EDT  MindMed to Present at Web Summit on Future of Mental Health   PR Newswire
Oct 26, 2021
07:19AM EDT  MindMed Announces Launch Of R(-)-MDMA Program   Benzinga
07:01AM EDT  MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program   PR Newswire
Oct 25, 2021
07:31AM EDT  MindMed CMO to Chair Digital Biomarkers Summit   PR Newswire
Oct 21, 2021
12:11PM EDT  Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race   Benzinga
Oct 20, 2021
09:28AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Oct. 20, 2021: TSLA, TLRY, MNMD, BBIG, SDIG   Benzinga
Oct 18, 2021
01:37PM EDT  Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation   Benzinga
Oct 13, 2021
04:25PM EDT  There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are   Benzinga
07:31AM EDT  MindMed Joins Clinical Trials Transformation Initiative   PR Newswire
Oct 11, 2021
02:21PM EDT  Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program   Benzinga
Oct 7, 2021
04:17PM EDT  Former Tilray CEO Joins Psychedelics Company   Benzinga
02:28PM EDT  'Third California City Moves To Decriminalize Psychedelics As Reform Movement Expands' -Marijuana Moment   Benzinga
Oct 6, 2021
11:12AM EDT  Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed   Benzinga
Oct 5, 2021
01:15PM EDT  MindMed Teams Up With Sphere Health To Identify Biomarkers Associated With Anxiety & Depression   Benzinga
07:36AM EDT  MindMed Announces Strategic Research Collaboration with Sphere Health To Collect And Analyze Multimodal Data In Order To Improve The Understanding Of A Variety Of Biomarkers Associated With Mental Illnesses Including Anxiety And Affective Disorders   Benzinga
07:35AM EDT  MindMed Announces Strategic Research Collaboration With Sphere Health   RTTNews
Oct 4, 2021
11:48PM EDT  Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed   Benzinga
11:53AM EDT  Psychedelic Front Runners MindMed , BioXcel Patent System To Identify Agitation   Benzinga
08:48AM EDT  COVID Tests, THC Patches, Psychedelics: Xphyto Therapeutics Does it All   Benzinga
Sep 30, 2021
03:16PM EDT  4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference   Benzinga
11:34AM EDT  From BZ's Small Cap Healthcare Conference: MinMed CEO, Robert Barrow Begins Speaking   Benzinga
08:52AM EDT  Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference   Benzinga
07:32AM EDT  MindMed Appoints Andreas Krebs And Carol Vallone As Directors And Transition Of Bruce Linton   RTTNews
07:31AM EDT  MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors   PR Newswire
Sep 29, 2021
02:23PM EDT  Digital Therapeutics And The Future Of Psychedelic Medicine   Benzinga
07:31AM EDT  MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist   PR Newswire
Sep 28, 2021
07:39AM EDT  MindMed To Present At The Benzinga Healthcare Small Cap Conference Sept. 30   Benzinga
07:31AM EDT  MindMed to present at the Benzinga Healthcare Small Cap Conference   PR Newswire
Sep 27, 2021
09:19AM EDT  Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study   Benzinga
Sep 23, 2021
07:31AM EDT  MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration   PR Newswire
Sep 22, 2021
09:53AM EDT  Mind Medicine Option Alert: Jan, 2024 $5 Calls Sweep (37) near the Ask: 319 @ $0.821 vs 246 OI; Ref=$2.4229   Benzinga
Sep 21, 2021
07:31AM EDT  MindMed Announces Participation at Upcoming Investor Conferences   PR Newswire
Sep 20, 2021
09:16AM EDT  'Italian Referendum To Decriminalize Marijuana, Psilocybin And Other Drug Plants Gets Half A Million Signatures' -Marijuana Moment   Benzinga
Sep 15, 2021
03:40PM EDT  Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0   Benzinga
Sep 14, 2021
12:54PM EDT  Meet The Top 12 CEOs In The Psychedelics Industry   Benzinga
Sep 10, 2021
07:30AM EDT  MindMed to Present at H.C. Wainwright 23rd Annual Global Investment Conference   PR Newswire
Sep 9, 2021
04:46PM EDT  Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?   Benzinga
07:31AM EDT  MindMed to Attend 8th Annual "Mobile in Clinical Trials" Conference   PR Newswire
Sep 7, 2021
02:31PM EDT  Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A   Benzinga
10:09AM EDT  EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation   Benzinga
Sep 3, 2021
12:00PM EDT  'Possessing And Cultivating Psychedelics Would Be Legalized In Michigan Under New Senate Bill' -Marijuana Moment   Benzinga
Sep 2, 2021
11:40AM EDT  EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation   Benzinga
07:33AM EDT  MindMed, BioXcel Report Publishing Of Int'l. Patent Application Describing System For Identifying Agitation Episodes   Benzinga
07:32AM EDT  MindMed And BioXcel Publish International Patent Application Describing System For Identifying Agitation Episodes   RTTNews
07:31AM EDT  MindMed and BioXcel Therapeutics Publish an International Patent Application   PR Newswire
Aug 31, 2021
11:01AM EDT  EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation   Benzinga
Aug 30, 2021
11:21AM EDT  Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold   Benzinga
Aug 24, 2021
11:18AM EDT  MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients   Benzinga
07:32AM EDT  MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders   Benzinga
07:31AM EDT  MindMed Announces Collaboration With Forian To Advance Development Of   PR Newswire
Aug 17, 2021
09:39AM EDT  Cramer Weighs In On RealReal, Affirm Holdings And More   Benzinga
07:31AM EDT  MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium   PR Newswire
Aug 16, 2021
08:54AM EDT  MindMed Reports Q2 Earnings With Net Loss of $36M And Cash Balance Of $157M To Continue With Its Clinical Pipeline   Benzinga
Aug 12, 2021
11:51PM EDT  MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million   PR Newswire
Aug 11, 2021
02:56PM EDT  What Do You Really Know About Psychedelics And Psychedelics Stocks?   Benzinga
Aug 10, 2021
07:31AM EDT  MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board   PR Newswire
Aug 9, 2021
08:26PM EDT  Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies   Benzinga
Aug 5, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021   Benzinga
07:22AM EDT  HC Wainwright & Co. Initiates Coverage On Mind Medicine with Buy Rating, Announces Price Target of $10   Benzinga
Aug 3, 2021
02:25PM EDT  Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies   Benzinga
07:31AM EDT  MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity   PR Newswire
Aug 2, 2021
10:08AM EDT  Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected   Benzinga
Jul 29, 2021
10:24AM EDT  MindMed Leverages Ayahuasca's Ingredient DMT In Psychedelic-Inspired Therapies, Launches Trials With 30 Subjects   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
07:24AM EDT  MindMed Reports Initiation Of Phase 1 Trial Of Intravenous DMT   Benzinga
07:21AM EDT  MindMed Unveils Initiation Of Phase 1 Trial Of Intravenous DMT   RTTNews
07:02AM EDT  MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT   PR Newswire
Jul 27, 2021
12:10PM EDT  'Massachusetts Lawmakers Discuss Bill To Create Psychedelics Legalization Task Force At Hearing' -Marijuana Moment Report   Benzinga
Jul 23, 2021
06:10PM EDT  Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To 'Psychedelics Renaissance'   Benzinga
05:04PM EDT  Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"   Benzinga
Jul 12, 2021
08:42AM EDT  Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline   Benzinga
07:31AM EDT  MindMed Chosen to Participate in Cowen's Psychedelics & Novel Mechanisms in   PR Newswire
Jul 8, 2021
08:23AM EDT  MindMed Announces Partnership With Datavant   RTTNews
08:21AM EDT  MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity   PR Newswire
Jul 7, 2021
01:51PM EDT  Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies   Benzinga
Jul 3, 2021
12:32PM EDT  Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies   Benzinga
Jun 30, 2021
06:14PM EDT  Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More   Benzinga
Jun 29, 2021
02:31PM EDT  Psychedelics-Focused MindMed Joins FTSE Russell 3000 Index, 'A True Honor'   Benzinga
Jun 28, 2021
12:50PM EDT  Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics'   Benzinga
10:21AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021   Benzinga
09:38AM EDT  UPDATE: Maxim Group On Mind Medicine: Firm Highlights Exclusive License For Data And Programs From University Hospital Basel's Liechti Lab, Granting Access To Copious Data And Any Intellectual Property Generated From Data.   Benzinga
09:37AM EDT  UPDATE: Maxim Group On Mind Medicine: Firm Believes Co. Has 'One Of The Most Diverse Pipelines In Psychedelics' With $160M In Cash.   Benzinga
07:59AM EDT  Maxim Group Initiates Coverage On Mind Medicine with Buy Rating, Announces Price Target of $6   Benzinga
07:36AM EDT  MindMed Included in FTSE Russell 3000 Index   Benzinga
Jun 25, 2021
10:25AM EDT  Mind Medicine Option Alert: Aug 20 $2.5 Calls Sweep (12) near the Ask: 1000 @ $1.301 vs 250 OI; Earnings 8/22 Before Open [est] Ref=$3.655   Benzinga
10:17AM EDT  Cannabis Movers & Shakers: HempFusion, Decibel, ARCA, Love Hemp, MindMed, Halo   Benzinga
Jun 23, 2021
07:33AM EDT  MindMed Appoints Maurizio Fava To Scientific Advisory Board   RTTNews
07:31AM EDT  MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific   PR Newswire
Jun 21, 2021
10:22AM EDT  Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform   Benzinga
Jun 18, 2021
05:12PM EDT  Peter Thiel-Backed Psychedelics Company Rings Nasdaq Bell: Atai Life Sciences Goes Public   Benzinga
Jun 17, 2021
07:35AM EDT  MindMed Appoints Peter Bergethon To Scientific Advisory Board   RTTNews
07:31AM EDT  MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific   PR Newswire
Jun 16, 2021
07:30AM EDT  The Science Behind Using Psychedelics To Treat   GlobeNewswire Inc
Jun 14, 2021
09:18AM EDT  Psyched: Atai's $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers   Benzinga
Jun 10, 2021
10:37AM EDT  EXCLUSIVE: Psychedelics Pioneer J.R. Rahn Unpacks Decision To Leave MindMed As CEO   Benzinga
Jun 9, 2021
09:06AM EDT  J.R. Rahn Steps Down As MindMed CEO   Benzinga
07:20AM EDT  Mind Medicine CEO J.R. Rahn To Resign, Robert Barrow Named Successor   RTTNews
07:19AM EDT  MindMed CEO J.R. Rahn To Step Down, Robert Barrow To Assume CEO Position   Benzinga
07:19AM EDT  Mind Medicine Says Robert Barrow To Succeed J.R. Rahn As CEO   RTTNews
07:17AM EDT  MindMed Announces Chief Executive Officer Transition   PR Newswire
Jun 8, 2021
01:12PM EDT  What Do You Really Know About Psychedelics And Psychedelics Stocks?   Benzinga
Jun 7, 2021
06:51AM EDT  Psyched: First Psychedelics ETF Comes To The US, Bills Move Forward In Texas, California and New York   Benzinga
Jun 2, 2021
10:36AM EDT  Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week   Benzinga
May 27, 2021
06:30PM EDT  MindMed announces shareholder Meeting Results   PR Newswire
09:18AM EDT  Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week   Benzinga
May 26, 2021
07:45AM EDT  MindMed Announces Publication Of First Pharmacogenetic Data On LSD To Help Personalize Dosing   RTTNews
07:30AM EDT  MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data   PR Newswire
May 24, 2021
12:06PM EDT  MindMed Collaborates with Nextage Therapeutics for Brain Targeting Liposome System   Benzinga
08:33AM EDT  Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research   Benzinga
07:40AM EDT  MindMed Announces Launch Of Collaboration With Nextage Therapeutics' Brain Targeting Liposome System   RTTNews
07:30AM EDT  MindMed Announces Launch of Collaboration with Nextage Therapeutics' Brain   PR Newswire
May 21, 2021
08:25AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Friday, May 21, 2021: PFPT, PIXY, MNMD, WAFU, ZS   Benzinga
May 20, 2021
04:17PM EDT  Cannabis Movers & Shakers: The Parent Company, MindMed, Australis, Flourish Software   Benzinga
02:27PM EDT  MindMed To Conduct The First Modern Research On Mescaline In Switzerland   Benzinga
07:31AM EDT  MindMed Announces the Approval of Mescaline Study   PR Newswire
May 19, 2021
10:27AM EDT  Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week   Benzinga
10:27AM EDT  Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week   Benzinga
May 18, 2021
06:30PM EDT  The Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the   PR Newswire
May 17, 2021
10:00AM EDT  MindMed Stock Moves Higher After Finalizing Generalized Anxiety Disorder As Initial Indication For LSD Trial   Benzinga
09:02AM EDT  Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public   Benzinga
07:37AM EDT  MindMed Announces Receipt Of Type C Meeting Responses From FDA For Project Lucy Phase 2b Clinical Trial   RTTNews
07:36AM EDT  MindMed Receives FDA Type C Meeting Response For Project Lucy Phase 2b Clinical Trial; Co. Says On Target To Submit IND Application In Q3   Benzinga
07:30AM EDT  MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical   PR Newswire
May 14, 2021
07:59AM EDT  Mind Medicine Appoints Sarah Vinson As A Director And A Member Of Its Audit Committee   RTTNews
07:56AM EDT  Mind Medicine Appoints Dr. Sarah Vinson As Director And Member Of Audit Committee, Effective Immediately   RTTNews
07:50AM EDT  MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director   PR Newswire
07:40AM EDT  MindMed Says Cash Balance As Of Mar. 31 Was $160M   Benzinga
07:33AM EDT  MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m   PR Newswire
May 13, 2021
02:16PM EDT  Benzinga Global Small Cap Conference: How Do Investors Pick Winners In The Psychedelics Space?   Benzinga
02:15PM EDT  How Do Investors Pick Winners In The Psychedelics Space?   Benzinga
12:11PM EDT  Video: Psychedelic Stocks With JLS Fund's Simeon Schnapper & MindMed's JR Rahn   Benzinga
11:33AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Notes LEss Than 10% Of $3.5T In Healthcare Spending On Mental Health; Says This Is 'Massive Opportunity' But To Get There, Must Be Able To Unite Psychiatrists And Therapists   Benzinga
11:28AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Says Thinks There Will Be Flight Of Institutional Capital To To Players In The Space   Benzinga
11:22AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Says Thinks Classic Psychedelics Such As MDMA, LSD And Psilocybin Will Open Up Market   Benzinga
11:19AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Says Way To Advance Pipeline Is To Partner With Companies That Have Larger Balance Sheets   Benzinga
11:18AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Highlights Multi-Substance Pipeline, Says Co.'s Target Market Is People Suffering From Mental Health Issues Says Co. With Most Diverse Pipeline Has 'Most Shots On Goal'   Benzinga
11:14AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Says Core Focus Is How To Get 'Classic Psychedelics' Like LSD Into Clinical Trials To Prove Safety And Efficacy   Benzinga
11:08AM EDT  From BZ Small Cap Event: MindMed CEO JR Rahn Begins Presentation at Benzinga's Global Small Cap Conference   Benzinga
07:31AM EDT  MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of   PR Newswire
May 11, 2021
10:40AM EDT  Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week   Benzinga
May 10, 2021
10:49AM EDT  Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M   Benzinga
May 6, 2021
05:46PM EDT  Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman   Benzinga
May 5, 2021
07:31AM EDT  MindMed Announces Project Angie, Targeting the Treatment of Pain with   PR Newswire
May 2, 2021
08:17AM EDT  Fintech Focus Roundup For May 2, 2021   Benzinga
Apr 30, 2021
10:37AM EDT  Exclusive: MindMed's Nasdaq Listing Enables Institutions Diversified Access To A New Age Of Medicine   Benzinga
09:05AM EDT  MindMed's Nasdaq Listing Enables Institutions Diversified Access To A New Age Of Medicine   Benzinga
Apr 27, 2021
07:31AM EDT  MindMed Begins Trading on Nasdaq   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC